Trusted Resources: News & Meetings
Latest announcements and gatherings
Gene Could Be New Tool to Help Predict Graves’ Disease Relapse
Patients with Graves’ disease who carry a specific gene show a more than seven-times increased risk of relapse after treatment, suggesting a potentially reliable and important biomarker in management of the disease.
There is a high risk of relapse in Graves’ disease, but there are currently no biomarkers proven to be predictors of relapse; the latter could be essential in disease management decision-making, a coauthor of the research explained.
“The risk of relapse in Graves’ disease is quite high — around 40% to 50% in Europe, and 70% to 80% in the United States,” said Masanobu Yamada, MD, PhD, of the Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan, in a press statement by Thyroid.
“Our finding may give us a tool to find at-risk patients at an earlier stage and more effectively tailor their treatment options,” said Dr Yamada.
myBinderRelated Content
-
Graves’ Disease After Treatment With Alemtuzumab for Multiple SclerosisContext: Alemtuzumab, a humanized monoc...
-
The British Thyroid FoundationThe British Thyroid Foundation (BTF) is ...
-
Pulmonary Arterial Hypertension in Patients with Hyperthyroid Graves’ Disease and Toxic Multinodular GoiterA number of case reports and small serie...
-
Randomized Trial of a Short Course of Preoperative Potassium Iodide in Patients Undergoing Thyroidectomy for Graves&...Background: A short course of potassium...
-
2018 European Thyroid Association Guideline for the Management of Graves’ HyperthyroidismGraves' disease (GD) is a systemic autoi...
-
The University of Kansas Medical CenterThe Head and Neck Surgery Team in the De...
-
Treatment of Hyperthyroidism With Antithyroid Drugs Corrects Mild Neutropenia in Graves’ DiseaseContext: Neutropenia secondary to antit...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Facebook
Google